AI is transforming the biologic drug development landscape, enabling faster and more efficient design of complex medicines. This shift could unlock new treatment possibilities for previously untreatable diseases.
AI models in radiology exhibit alarming confidence in incorrect diagnoses, highlighting the need for improved decision-making capabilities before they can operate independently.
XCures, a pioneering startup focused on enhancing patient data management through artificial intelligence, has successfully closed a $46 million Series B funding round, as reported...
DeepMind has announced the launch of a groundbreaking 27 billion parameter foundation model designed for single-cell analysis, expanding upon the existing Gemma family of open mode...
DeepMind has made a significant advancement in the understanding of heart disease by revealing the structure of a critical protein associated with the condition. Utilizing its grou...
Since its inception five years ago, AlphaFold has revolutionized the field of biology by providing unprecedented insights into protein structures. This groundbreaking AI technology...
DeepMind has launched AlphaGenome, a cutting-edge DNA sequence model designed to enhance the understanding of genome function and improve the prediction of regulatory variant effec...
